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Abstract 
A variety of extrapancreatic lesions have been associated with autoimmune pancreatitis 
(AIP), and these lesions can be difficult to diagnose. We report a patient referred to 
Shizuoka Cancer Center with the diagnosis of a possible biliary carcinoma with liver 
metastasis who was shown to have AIP accompanied by pseudotumors of liver. Clinical 
imaging revealed diffuse enlargement of the head of the pancreas with irregular 
narrowing of the main pancreatic duct and inferior common bile duct, multiple liver 
masses, mediastinal lymphadenopathy, and thickening of the wall of the gallbladder and 
abdominal aorta. Cytology and biopsy from the pancreaticobiliary tract was negative for 
malignancy. Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) 
levels were in the normal range, but soluble interleukin 2 receptor (sIL2R), IgG4 and 
antinuclear antibody were abnormally high (sIL2R: 2,550 U/ml; IgG4: 764 mg/dl). 
Corticosteroid therapy was effective and these abnormal findings all improved. This case 
demonstrates the clinical importance of AIP accompanied by other systemic disorders in 
the differential diagnosis of patients with a pancreatic mass lesion. 
 
Case Report 
In March 2006, a 62-year-old man was referred from another hospital with diagnosis of possible 
distal bile duct carcinoma with liver metastasis. The patient’s chief complaint was jaundice. He denied 
abdominal pain, fever, fatigue, appetite loss, and weight loss. The patient’s history was remarkable for  
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hypertension, gout and diabetes mellitus, and he routinely took peroral medications for these disorders. 
He had bilateral, multiple renal cysts, but no history of renal dysfunction. His brother had died of 
pancreatic cancer, otherwise his family history was unremarkable. On admission, physical findings were 
significant only for jaundice. Blood tests included bilirubin 2.8 mg/dl (after biliary drain insertion at the 
previous hospital), GOT 51 U/l, GPT 119 U/l, alkaline phosphatase 972 U/l, amylase 36 U/l (normal 43–
116 U/l), BUN 13.3 mg/dl, creatinine 1.02 mg/dl, glucose 198 mg/dl, HbA1c 8.8% (normal 4.3–5.8%), 
hemoglobin 11.6 g/dl, and eosinophils 23% (normal 0–6%). Hepatitis B virus surface antigen and 
hepatitis C virus antibody were both negative. High levels of serum immunoglobulin G (1,977 mg/dl; 
normal 870–1,700 mg/dl) were recognized, particularly IgG4 (764 mg/dl; normal 4.8–105 mg/dl). RA 
test, anti-SSA and anti-SSB were negative, but antinuclear antibody was positive. Serum tumor markers 
such as CEA and CA19-9 were in the normal range (2.4 ng/ml and 24 U/ml, respectively), but sIL2R 
(2,550 U/ml) was about five times as high as the upper limit of normal (220–530 U/ml). 
After admission, diagnostic examination included abdominal ultrasonography (US) (fig. 1) and 
contrast-enhanced computer tomography (CT) (fig. 2) which revealed four nodular lesions in the liver 
(maximum 10 mm), swelling of the pancreatic head and thickening of the wall of the gallbladder and 
abdominal aorta. T2-weighted SPIO-MRI showed multiple high-signal nodules in the liver. PET-CT 
revealed accumulation of FDG not only at the head of the pancreas, in the multiple liver masses, 
gallbladder and abdominal aorta, but also in multiple mediastinal lymph nodes. No obvious lymph node 
swelling was recognized around the abdominal aorta. ERCP demonstrated irregular narrowing of main 
pancreatic duct and lower common bile duct (fig. 3). With the combination of pancreatic head 
enlargement with narrowing of the main pancreatic duct and high serum levels of IgG, IgG4 and 
positive antinuclear antibody, the diagnostic criteria of AIP [1] were satisfied. To exclude cancer, we 
twice repeated biopsy (five sites each time) and brushing cytology from the narrowing site of the 
pancreaticobiliary duct. Tissue and fluid samples showed no evidence of an epithelial neoplasm and 
regenerating epithelial cells with abundance of inflammatory cells. IgG4-positive lymphocytes were 
sporadically recognized within the tissue (fig. 4). An endoscopic biliary drain was exchanged to prevent 
recurrence of the patient’s jaundice. The clinical findings were compatible with AIP accompanied by 
mediastinal lymphadenopathy [1], pseudotumors of the liver [1–5], chronic cholecystitis, and 
periaortitis. Oral treatment with 40 mg prednisolone was initiated and gradually decreased. Three 
months later, the imaging findings were all improved. The patients IgG, IgG4 and eosinophil count had 
also improved to 1,357 mg/dl, 399 mg/dl, and 6.8%, respectively. A year and ten months later, the 
patient was in healthy physical condition, had stopped steroid intake, and his serum creatinine level had 
improved from 1.25 to 1.02 mg/dl, but he still had weak proteinuria. Serum glucose and HbA1c levels 
did not change significantly during the course of treatment. 
Discussion 
AIP is a systemic disease which, in addition to the pancreas, is known to affect multiple 
organs such as bile duct, cervical and abdominal lymph nodes, salivary gland, 
retroperitoneum, peripancreatic artery and vein [1, 6, 7]. Usually, this type of pancreatitis 
recovers structurally and functionally when the ductal obstruction is removed or the 
inflammation disappears after steroid administration [8]. According to a Japanese 
nationwide survey [9], the incidence of AIP was 0.82 per 100,000 people in 2002, with a 
higher ratio of males (2.85 times that of females). More than 95% of patients were past 
middle age (>45 years). In this report, we present a patient with AIP with a variety of 
systemic disorders including mediastinal lymphadenopathy, hepatic pseudotumors, 
chronic cholecystitis, periaortitis, renal dysfunction and diabetes mellitus. 
Because of the existence of multiple hepatic lesions, the possibility of pancreaticobiliary 
cancer with liver metastasis was considered. To date, four cases of AIP with pseudotumor 
of the liver, mimicking pancreaticobiliary carcinoma with liver metastasis, have been 
documented in the literature [2–5]. Several features helped establish the diagnosis in this 
case. First, the head of the pancreas was diffusely enlarged without a localized mass lesion. 
Second, the pancreatic duct was narrowed over a long length without an abrupt stenosis. 
These findings favored chronic inflammation in the head of the pancreas over carcinoma 
and were mentioned in the main condition of Japanese diagnostic criteria of AIP [1].  
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Serological data, such as high levels of serum IgG, IgG4 and positive antinuclear antibody, 
strongly supported the existence of IgG4-related autoimmune disease [7]. Hence, this case 
satisfied two of three conditions of diagnosis of the Japanese AIP criteria, i.e. clinical 
image and serum data, leading to the definitive diagnosis of AIP. Histocytology of tissue 
and fluid samples repeatedly obtained from the pancreaticobiliary tract, although non-
diagnostic, may help exclude pancreaticobiliary cancer. 
A broad differential diagnosis must be kept in mind when establishing a diagnosis in a 
patient with a mass-forming pancreatic lesion [10–13]. Time is of essence as many of 
these lesions grow rapidly [10–12] and the consequences of an accurate diagnosis are 
significant as therapy will vary greatly from high-dose chemotherapy to 
immunosuppression [1]. 
As for the hepatic lesions in our case, faint low echoic change by US and non-
demarcated, low-density finding by enhanced CT supported the diagnosis of an 
inflammatory pseudotumor over that of metastastic carcinoma. Hepatic inflammatory 
pseudotumors sometimes show histology with IgG4-positive lymphoplasmacytic 
aggregation. Although no histological evidence was obtained from hepatic lesions, the 
therapeutic effect of corticosteroid [3, 4] also supported the diagnosis of inflammatory 
pseudotumor. 
We also noticed aortic wall thickness and renal dysfunction. AIP is known to be 
accompanied with obstructive phlebitis [14, 15] in small- to medium-sized veins, but not 
periaortitis. Similar to the hepatic lesion, we were not able to establish a definitive 
diagnosis of periaortitis with the histological evidence, because open biopsy of the 
abdominal wall is too invasive and in contrast, US and CT [16, 17] certainly support the 
diagnosis of chronic periaortitis [16]. Chronic periaortitis often accompanies peritoneal 
fibrosis, an extrahepatic lesion recognized in 10% of patients with AIP, and, like AIP, 
periaortitis is also caused by immune response to an antigen, only in the case an antigen 
localized to the aortic adventitia [18]. When periaortitis and retroperitoneal fibrosis are  
advanced, they can lead to aortic rupture and renal failure due to ureteric obstruction, so 
early detection is important. Immunosuppression with steroids or other agents is the 
preferred initial therapy, and if this is not effective, surgery is another option [16]. The 
patient we present also had renal dysfunction. As the patient did not have ureteric 
obstruction, other causes should be considered. For example, tubulointestinal nephritis is 
a recognized IgG4-related systemic disease [19]. Although we did not have periaortic or 
renal tissue to study, the efficacy of the steroid therapy suggests that periaortitis and renal 
diseases were a manifestation of this person’s autoimmune disease. Clinicians should keep 
in mind that these findings may accompany AIP as part of a broader systemic 
autoimmune disorder. 
Our case demonstrates the importance of clinical diagnosis using clinical imaging, 
blood tests and histological tests when AIP is associated with other systemic disorders. 
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Fig. 1. Abdominal US. Multiple low-echoic nodules can be seen in the right lobe of the liver (a). The 
gallbladder wall is thickened (b). The pancreatic head is enlarged with low echoic change. The main 
pancreatic duct is slightly dilated in the body of the pancreas (c). The anterior side of aortic adventitia 
(arrows) is swollen (d). 
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Fig. 2. Contrast-enhanced CT. Multiple low-density lesions were recognized in the right lobe of the 
liver (a, b). The wall of the gallbladder is thickened (c). The head of the pancreas (arrow) is enlarged 
with spotty low-density change. Biliary drain was inserted into the lower bile duct (d). The anterior wall 
of the abdominal aorta (arrow) is thickened (e), a finding which improved after steroid therapy (f). 
 
 
 
Fig. 3. Endoscopic retrograde cholangiopancreatography. A long segment of narrowing, without abrupt 
stenosis, was recognized in the main pancreatic duct at the pancreatic head (b) and lower bile duct (a). 
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Fig. 4. Histological sample from the biliary duct at the stenotic site. Abundant inflammatory cells are 
associated with regenerating epithelial cells (a) (H&E, ×200). IgG4-positive lymphocytes were 
sporadically recognized within the tissue (b) (IgG4 antibody, ×200). 
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